Summary
- Main use
- Treatment of hypocitraturic calcium oxalate stones, uric acid stones, and renal tubular acidosis accompanied by calcium stones
- Who takes it
- Adults
- Adult dose
- During treatment with this medicine, follow a diet that restricts salt intake (avoid foods containing a high amount of salt and avoid adding salt) and includes increased fluid intake (so that urine output is at least 2 liters per day). The purpose of treatment with this medicine is to increase urinary citrate to at least 320mg/day and, if possible, close to the normal value of 640mg/day, and to increase urine pH to 6.0 - 7.0. 1) Patients with severe hypocitraturia (urinary citrate 150mg/day or less): The initial dose is 60mEq (6 tablets) per day, taken in 3-4 divided doses during or after meals, or within 30 minutes after a bedtime snack. 2) Patients with mild or moderate hypocitraturia (urinary citrate greater than 150mg/day): The initial dose is 30mEq (3 tablets) per day, taken as 10mEq (1 tablet) 3 times daily with meals. Measure urinary citrate concentration and urine pH in a 24-hour urine collection every 4 months to determine the appropriate initial dose and assess the effect when adjusting the dose. Doses exceeding 100mEq(10,800mg) per day have not been studied and should not be administered. Measure serum electrolytes, serum creatinine, complete blood count (CBC), etc., every 4 months. Discontinue treatment if hyperkalemia, a rapid increase in serum creatinine, or a marked decrease in hemoglobin or hematocrit occurs. Adjust the dose appropriately according to age and symptoms.
Ingredients
- Manufacturer
- Korea Pharma Bio Co., Ltd.
Efficacy & effects
Treatment of hypocitraturic calcium oxalate stones, uric acid stones, and renal tubular acidosis accompanied by calcium stones
- Renal tubular acidosis with calcium stones
- calcium oxalate stone disease with low urinary citrate levels
- uric acid stone disease
View approved original textHide original text
This medication is used to treat renal tubular acidosis with calcium stones and calcium oxalate stones with low urinary citrate levels. It is also effective in the treatment of uric acid stone disease, regardless of the presence of calcium stones. In other words, it helps in the treatment of diseases related to various types of kidney stones.
How to take
Adult dose
During treatment with this medicine, follow a diet that restricts salt intake (avoid foods containing a high amount of salt and avoid adding salt) and includes increased fluid intake (so that urine output is at least 2 liters per day). The purpose of treatment with this medicine is to increase urinary citrate to at least 320mg/day and, if possible, close to the normal value of 640mg/day, and to increase urine pH to 6.0 - 7.0. 1) Patients with severe hypocitraturia (urinary citrate 150mg/day or less): The initial dose is 60mEq (6 tablets) per day, taken in 3-4 divided doses during or after meals, or within 30 minutes after a bedtime snack. 2) Patients with mild or moderate hypocitraturia (urinary citrate greater than 150mg/day): The initial dose is 30mEq (3 tablets) per day, taken as 10mEq (1 tablet) 3 times daily with meals. Measure urinary citrate concentration and urine pH in a 24-hour urine collection every 4 months to determine the appropriate initial dose and assess the effect when adjusting the dose. Doses exceeding 100mEq(10,800mg) per day have not been studied and should not be administered. Measure serum electrolytes, serum creatinine, complete blood count (CBC), etc., every 4 months. Discontinue treatment if hyperkalemia, a rapid increase in serum creatinine, or a marked decrease in hemoglobin or hematocrit occurs. Adjust the dose appropriately according to age and symptoms.
Precautions
This drug is used to regulate potassium levels in the body, and when administered to patients who have difficulty excreting potassium, it can cause dangerously high blood potassium levels, leading to serious cardiac problems. Patients with hyperkalemia or a history of it, chronic renal failure, myocardial injury, heart failure, uncontrolled diabetes, acute dehydration, ongoing strenuous exercise, adrenal insufficiency, extensive tissue damage, and those taking potassium-sparing diuretics should not use this drug. Also, it is safer not to administer to patients who have difficulty swallowing or gastrointestinal motility issues, delayed gastric emptying, esophageal stenosis, gastrointestinal obstruction, gastric ulcers, and those with certain urinary tract infections. After taking this medication, gastrointestinal disturbances such as abdominal discomfort, nausea, vomiting, and diarrhea may occur. These symptoms can be alleviated by taking the medication with meals or by reducing the dosage. This drug can irritate the gastric mucosa, and if severe vomiting, abdominal pain, or gastrointestinal bleeding occurs, the medication should be stopped immediately, and medical attention should be sought. The prescribed dosage should be strictly followed, and patients taking diuretics or heart-related medications need to be especially cautious. When taking the medication, if there is difficulty swallowing or a sensation of the tablet stuck in the throat, it must be reported to a doctor. Regular monitoring of blood potassium levels is required, and patients with heart disease, kidney disease, and acidosis need closer observation. Taking potassium-sparing diuretics together can lead to dangerously high hyperkalemia, so co-administration should be avoided. Drugs that slow gastrointestinal motility, such as anticholinergics, may increase gastrointestinal irritation when taken together. Patients taking non-steroidal anti-inflammatory drugs (NSAIDs) should be carefully monitored due to the risk of elevated potassium levels. Pregnant or breastfeeding women should use this drug only when absolutely necessary, due to insufficient information on its effects on the fetus or newborn, and caution is also needed during breastfeeding. Safety and efficacy for pediatrics have not yet been established, so it should be used with caution in children. In cases of overdose, there can be a rapid increase in blood potassium levels leading to muscle paralysis or cardiac arrest, requiring immediate treatment, and cessation of potassium-rich food or drug intake and treatment under medical supervision. This drug should be swallowed whole as a tablet; it should not be crushed or chewed.
Side effects
- abdominal discomfort
- nausea
- vomiting
- diarrhea
- decreased bowel movement
- gastrointestinal irritation
- gastrointestinal bleeding
- severe vomiting
- abdominal pain
- gastrointestinal damage
Not everyone experiences these, and they can vary from person to person.
Storage
This drug may be sensitive to air or moisture; therefore, it must be stored in a tightly sealed container. Additionally, it is important to maintain a room temperature of between 1 and 30 degrees Celsius while storing the medication. This will help preserve the medication's efficacy for a longer period.
Appearance and packaging
Appearance
White convex rectangular tablet
Package unit
90 tablets/bottle, 30 tablets/bottle, 90 tablets (10 tablets/PTP x 9)/box, 14 tablets/bottle (for export)
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
